Article
The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.
Thrombosis research - 1 Apr 2009
Tsangaris Iraklis, Tsantes Argiris, Bonovas Stefanos, Lignos Michalis, Kopterides Petros, Gialeraki Argiro, Rapti Evdoxia, Orfanos Stylianos, Dimopoulou Ioanna, Travlou Anthi, Armaganidis Apostolos
Abstract excerpt
INTRODUCTION: Increased levels of plasminogen activator inhibitor-1 (PAI-1) have been associated with worse outcome in ALI/ARDS. A single guanosine insertion/deletion (4G/5G) polymorphism in the promoter region of the PAI-1 gene, may play an important role in the regulation of PAI-1 expression. The objective of the study was to evaluate the effect of this polymorphism on the outcome of critically ill patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
